Comparison of the efficacy, safety and tolerability of azithromycin and co-amoxiclav in the treatment of acute periapical abscesses

Journal of International Medical Research

Volumn 26, Issue 5, 1998, Pages 257-265

  Adriaenssen, C F ^a,b  

^a Department of Stomatology   (Belgium)

^b Department of Stomatology   (Belgium)

Author keywords

Anaerobes; Antibacterial drugs; Azithromycin; Co amoxiclav; Efficacy; Periapical abscess

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIARRHEA; EDEMA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RADIODIAGNOSIS; SOFT TISSUE; TOOTH PAIN; TOOTH PERIAPICAL DISEASE;

EID: 0032440186     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059802600506     Document Type: Article

References (23)

1. Sundqvist G: Associations between microbial species in dental root canal infections. Oral Microbiol Immunol 1992; 7: 257-262.
2. Lejeune H, Amedee RG: A review of odontogenic infections. J La State Med Soc 1994; 146: 239-241.
3. Hardie J: Oral microbiology: current concepts in the microbiology of dental caries and periodontal disease. Br Dent J 1992; 172: 271-278.
4. Soloman C, Chalfin H, Kellert M, et al: The endodontic-periodontal lesion: a rational approach to treatment. J Am Dent Assoc 1995; 126: 473-479.
5. Vigil GV, Wayman BE, Dazey SE, et al: Identification and antibiotic sensitivity of bacteria isolated from periapical lesions. J Endod 1997; 23: 110-114.
6. Russell RR: Bacteriology of periodontal disease. Curr Opin Dent 1992; 2: 66-71.
7. Selzer S, Farber PA: Microbiologic factors in endodontology. Oral Surg Oral Med Oral Pathol 1994; 78: 634-645.
8. Sundqvist G: Taxonomy, ecology, and pathogenicity of the root canal flora. Oral Surg Oral Med Oral Pathol 1994; 78: 522-530.
9. Sefton AM, Maskell JP, Beighton D, et al: Azithromycin in the treatment of periodontal disease; effect on microbial flora. J Clin Periodontol 1996; 23: 998-1003.
10. van Winkelhoff AJ, Carlee AW, de Graff J: Bacteroides endontalis and other black pigmented Bacteroides species in odontogonic abscesses. Infect Immun 1985; 49: 494-497.
11. Williams JD, Maskell JP, Shain H, et al: Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms. J Antimicrob Chemother 1992; 30: 27-37.
12. Foulds G, Shepherd RM, Johnson RB: The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990; 25 (Suppl A): 73-82.
13. Bergogne Bérézin E: Azithromycine: pharmocologie tissulaire. Pathol Biol (Paris) 1995; 43: 498-504.
14. Malizia T, Tejada MR, Ghelardi E, et al: Peridontal tissue disposition of azithromycin. J Periodontol 1997; 68: 1206-1209.
15. Sasaki J, Kaneko A, Karakida K, et al: Comparative clinical study of azithromycin with tosufloxacin tosilate in the treatment of acute odontogenic infection. Jpn J Antibiot 1995; 48: 1093-1118.
16. Filatova NA, Kuznetsov EA, Dmitrieva LA, et al: The prospects for using the new macrolide antibiotic azithromycin (Sumamed) in the combined treatment of periodontitis. Stomatologiia (Mosk) 1995; 74: 12-25.
17. Lo Bue AM, Sammartino R, Chisari G, et al: Efficacy of azithromycin compared with spiramycin in the treatment of odontogenic infections. J Antimicrobial Chemother 1993; 31 (Suppl E): 119-127.
18. Wise R: The pharmacokinetics of azithromycin. Rev Contemp Pharmacother 1994; 5: 329-340.
19. Gladue RP, Bright GM, Isaacson RE, et al: In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanisms of delivery and release at sites of infection. Antimicrob Agents Chemother 1989; 33: 277-282.
20. Fisher LE, Russell RR: The isolation and characterization of milleri group streptococci from dental periapical abscesses. J Dent Res 1993; 72: 1191-1193.
21. Slots J, Bragd L, Wikstrom M, et al: The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius in destructive periodontal disease in adults. J Clin Periodontol 1986; 13: 570-577.
22. Pajukanta R, Asikainen S, Saarela M, et al: In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans. Antimicrob Agents Chemother 1992; 36: 1241-1243.
23. Pajukanta R: In vitro antimicrobial susceptibility of Porphyromonas gingivalis to azithromycin, a novel macrolide. Oral Microbiol Immunol 1993; 3: 325-326.